Woodline Partners’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $366K | Sell |
|
|||||
|
2024
Q4 | $6.14M | Sell |
|
|||||
|
2024
Q3 | $44.3M | Sell |
|
|||||
|
2024
Q2 | $35.5M | Buy |
|
|||||
|
2024
Q1 | $50.4M | Buy |
|
|||||
|
2023
Q4 | $23.2M | Sell |
|
|||||
|
2023
Q3 | $22.9M | Buy |
|
|||||
|
2023
Q2 | $11.2M | Buy |
|
|||||
|
2023
Q1 | $8.46M | Buy |
|
|||||
|
2022
Q4 | $9.45M | Sell |
|
|||||
|
2022
Q3 | $12.9M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $14M | Buy |
|
|||||
|
2021
Q4 | $4.46M | Sell |
|
|||||
|
2021
Q3 | $7.43M | Buy |
|